• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Amphastar Pharma (NQ: AMPH )

    50.73 +0.20 (+0.40%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 181,188
    Open 50.75
    Bid (Size) 49.73 (1)
    Ask (Size) 51.68 (1)
    Prev. Close 50.53
    Today's Range 50.25 - 51.22
    52wk Range 36.56 - 65.92
    Shares Outstanding 48,675,822
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Amphastar Casts Wide Net, Hauls In Profits, Gets Rating Upgrade
    Amphastar hit an all-time high in August 2023 and consolidated. It could be forming the right side of a cup base that started in January. 
    Via Investor's Business Daily
    JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability
    JP Morgan assesses the specialty pharma sector, highlighting robust fundamentals and new product excitement. Key focus on Teva, Organon, and Viatris. 
    Via Benzinga

    Performance

    YTD
    -18.56%
    -18.56%
    1 Month
    +4.92%
    +4.92%
    3 Month
    +19.51%
    +19.51%
    6 Month
    +18.92%
    +18.92%
    1 Year
    +11.64%
    +11.64%

    More News

    Read More
    Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference
    Via ACCESSWIRE
    AMPH Stock Earnings: Amphastar Pharma Beats EPS, Beats Revenue for Q2 2024
    Via InvestorPlace
    Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2024
    Via ACCESSWIRE
    Why the growth investor may take a look at NASDAQ:AMPH.
    Via Chartmill
    Exploring NASDAQ:AMPH's growth characteristics.
    Via Chartmill
    Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024
    Via ACCESSWIRE
    NASDAQ:AMPH, an undervalued stock with good fundamentals.
    Via Chartmill
    Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7, 2024
    Via ACCESSWIRE
    7 Biotech Stocks to Buy on the Dip: June 2024
    Via InvestorPlace
    Top 2 Small Cap Healthcare Stocks to Buy Before Rate Cuts
    Via MarketBeat
    Topics ETFs Economy
    Exposures Interest Rates
    Amphastar Announces Additional $50 Million Increase to its Share Buyback Program
    Via ACCESSWIRE
    Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
    Via ACCESSWIRE
    Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023
    Via ACCESSWIRE
    Delving into NASDAQ:AMPH's Growth Prospects.
    Via Chartmill
    Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol
    Via ACCESSWIRE
    Patent Peril: 3 Stocks at Risk From the FTC’s Drug Crusade
    Via InvestorPlace
    Topics Intellectual Property
    Exposures Intellectual Property
    Amphastar Pharmaceuticals to Present at the Bank of America Securities Health Care Conference
    Via ACCESSWIRE
    AMPH Stock Earnings: Amphastar Pharma Beats EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    Federal Trade Commission Targets 'Junk Patent Listings' For Diabetes, Weight Loss, Asthma Drugs From Companies Like Novo Nordisk, AstraZeneca
    Via Benzinga
    Topics Intellectual Property
    Exposures Intellectual Property
    Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024
    Via ACCESSWIRE
    Amphastar Pharmaceuticals Interested In Potential Acquisitions In Endocrinology-Focused Companies
    Via Benzinga
    Amphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference
    Via ACCESSWIRE
    Amphastar Pharmaceuticals to Present at the Barclays 26th Annual Global Healthcare Conference
    Via ACCESSWIRE
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.